Grantham, Mayo, Van Otterloo & Co (GMO)’s Celanese CE Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,860	Closed	-$313K	–	704
2021 Q4	$313K	Buy	+1,860	New	+$303K	﹤0.01%	647
2019 Q4	–	Sell	-17,000	Closed	-$2.08M	–	694
2019 Q3	$2.08M	Sell	17,000 -21,500	-56%	-$2.42M	0.01%	421
2019 Q2	$4.15M	Sell	38,500 -18,100	-32%	-$1.87M	0.03%	332
2019 Q1	$5.58M	Sell	56,600 -38,500	-40%	-$3.79M	0.04%	252
2018 Q4	$8.56M	Buy	95,100 +32,000	+51%	+$3.14M	0.07%	153
2018 Q3	$7.19M	Buy	+63,100	New	+$7.24M	0.05%	178
2016 Q3	–	Sell	-8,100	Closed	-$530K	–	530
2016 Q2	$530K	Sell	8,100 -2,500	-24%	-$174K	﹤0.01%	464
2016 Q1	$694K	Buy	+10,600	New	+$658K	﹤0.01%	443

Other funds holding CE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CE Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Celanese (CE) in Q1 2022, closing a stake of 1,860 shares — an estimated $313K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CE in Q1 2016 and held it in 8 quarters. The position peaked at $8.56M in Q4 2018. 683 funds tracked by Wall St. Rank hold CE as of Q1 2022.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Celanese position as of Q1 2022 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,860 Celanese shares in Q1 2022, an estimated $313K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Celanese in Q1 2016 and held it in 8 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Celanese position peaked at $8.56M in Q4 2018.
683 funds tracked by Wall St. Rank held Celanese as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.